STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep prostate cancer from coming back after surgery
Disease control OngoingThis study is for men whose prostate cancer has returned after surgery, shown by a rising PSA. It compares standard radiation therapy alone versus radiation plus a drug called apalutamide, which blocks male hormones that fuel cancer growth. The goal is to see if the combination d…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 09:50 UTC
-
New drug combo shows promise against tough prostate cancer
Disease control OngoingThis study tests whether adding cediranib to olaparib works better than olaparib alone for men with a type of advanced prostate cancer that has spread and stopped responding to hormone therapy. About 90 men will take part. The goal is to see if the combination can slow cancer gro…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 09:50 UTC
-
Can prostate removal boost survival in advanced cancer?
Disease control OngoingThis study tests whether surgically removing the prostate, along with hormone therapy and possibly chemotherapy, helps men with prostate cancer that has spread to other parts of the body. About 190 men with newly diagnosed metastatic prostate cancer will be randomly assigned to r…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 17, 2026 09:48 UTC
-
New hope for tough prostate cancer: drug cocktail trial underway
Disease control OngoingThis study tests different combinations of approved drugs to see which works best for men with advanced prostate cancer that has stopped responding to hormone therapy. About 200 men will receive either a standard hormone-blocking combo or that combo plus an immunotherapy or chemo…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 09:37 UTC
-
Double-Drug attack shows promise for tough prostate cancer
Disease control OngoingThis study tests whether adding the chemotherapy drug cabazitaxel to the hormone therapy abiraterone works better than abiraterone alone for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapy. About 223 men who have already r…
Matched conditions: STAGE IV PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 11, 2026 20:38 UTC